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After acquiring competence for selected cell fates, embryonic primordia may remain plastic for variable periods
before tissue identity is irrevocably determined (commitment). We investigated the chromatin basis for these
developmental milestones in mouse endoderm, a tissue with recognizable rostro–caudal patterning and transcrip-
tion factor (TF)-dependent interim plasticity. Foregut-specific enhancers are as accessible and active in early midgut
as in foregut endoderm, and intestinal enhancers and identity are established only after ectopic cis-regulatory ele-
ments are decommissioned.Depletion of the intestinal TFCDX2 before this cis element transition stabilizes foregut
enhancers, reinforces ectopic transcriptional programs, and hence imposes foregut identities on themidgut. Later in
development, as the window of chromatin plasticity elapses, CDX2 depletion weakens intestinal, without
strengthening foregut, enhancers. Thus, midgut endoderm is primed for heterologous cell fates, and TFs act on
a background of shifting chromatin access to determine intestinal at the expense of foregut identity. Similar
principles likely govern other fate commitments.
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plasticity; chromatin plasticity; homeodomain transcription factors]
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After embryonic cells acquire the competence to develop
into a limited number of tissues, adult cell fates are deter-
mined in phases (Slack 1991). Possible cell identities are
first specified, and developmental potential may remain
flexible for some period until cells commit to unilineage
differentiation. Each of these steps has a basis in transcrip-
tion factor (TF) interactions with specific cis-regulatory
elements (Shlyueva et al. 2014; Long et al. 2016). Enhanc-
ers recruited early in tissue ontogeny confer competence
(Nord et al. 2013; Lara-Astiaso et al. 2014); cell identities
emerge as organ primordia activate these and subsequent-
ly additional enhancers (Stergachis et al. 2013; Wang et al.
2015). For example, when human embryonic stem cells
(ESCs) differentiate into pancreatic, liver, or lung lineages,
the active histone mark H3K4me1 is found on a large
swath of enhancers, signifying broad tissue competence
(Wang et al. 2015). Later, inductive signals drive different
cell populations to stabilize a fraction of this early enhanc-
er pool and thereby commit to a single fate.
We investigated the logic underlying enhancer recruit-
ment and dynamic TF interactionswith chromatin during
development of the mouse alimentary canal, where dis-
tinctive epithelia with diverse morphologies and func-
tions arise from undifferentiated gut endoderm. Because
cell migration along the rostro–caudal axis is limited,
the mucosa of each gut segment descends largely and
directly from the corresponding regional endoderm
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(Fig. 1A). The molecular mechanisms are pertinent to hu-
man health because gastrointestinal atresias and malfor-
mations are among the commonest congenital disorders
and because the largest risk for stomach and lower esoph-
ageal cancers occurs after native adult epithelia acquire
heterologous (intestinal) character.
The pseudostratified epithelium lining the primitive
mouse gut tube responds to regional cues to establish fore-
gut (FG), midgut, and hindgut domains (Zorn and Wells
2009; Spence et al. 2011).Windows of developmental plas-
ticity are evident within these domains before cells adopt
definitive squamous (esophagus [Eso] and forestomach
[FS]) or columnar epithelial (glandular stomach and intes-
tine) identities (Wells and Melton 1999; Grapin-Botton
and Melton 2000). Some TFs are expressed broadly before
approximately embryonic day 9 (E9)—when Wnt, bone
morphogenetic protein (BMP), and other signals help es-
tablish an anterior–posterior pattern—and are later re-
stricted to specific regions (Wells and Melton 2000).
Moreover, endoderm transplanted before E13 adopts the
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Figure 1. Transcriptional and chromatin landscapes in the developing and neonatal gut. (A) Gut epithelia with distinctive morphologies
arise from contiguous endodermal regions. (Eso) Esophagus; (FS) forestomach; (HS) hindstomach; (Int) small intestine. (B) Principal com-
ponent analysis (PCA) of Eso/FS (red), HS (purple), and Int (blue) transcriptomes at embryonic day 12 (E12), E14, and E16. n= 2 per group.
The largest sources of variation reflect the emergence of tissue-specificmRNAprofiles after E14. Photomicrographs of intestinal endoderm
show pseudostratified epithelium at E12, early villus formation at E14, andmature villus structures at E16. (C ) Differential chromatin ac-
cess in postnatal day 1 (P1) endoderm from different regions of the tubal gut. Each cluster of ATAC-seq (assay for transposase-accessible
chromatin [ATAC] using sequencing) summits ±1.5 kb represents candidate enhancers selectively accessible in one region or common
to the FS and HS (Overlap). In adult intestinal villi, the enhancers identified in P1 intestine carry H3K4me1, H3K27ac, and RNAPII, but
these marks are largely missing from enhancers detected in P1 foregut tissues. Integrated Genome Viewer (IGV) tracks show ATAC-seq
andRNAsequencing (RNA-seq) data at representative loci fromEso/FS and Int clusters.Numbers represent signal scales, and shadedboxes
highlight region-specific enhancers. (D) Gene set enrichment analysis (GSEA) of genes locatedwithin 50kbof sites selectively accessible in
theEso/FSor Int (derivedusing binding and expression target analysis [BETA]) (Wang et al. 2013), plottedwith respect to differentialmRNA
expression in the E16 Eso/FS and Int. (NES) Normalized enrichment score.
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regional identity of the host segment, whereas transplants
of more advanced endoderm retain the identity of the
donor region (Mizuno and Yasugi 1990; Duluc et al.
1994; Yasugi and Mizuno 2008). The chromatin and TF
bases for initially labile midgut cell fate and subsequent
commitment to intestinal differentiation are unclear.
In mid-gestation and beyond, the TF CDX2 is restricted
to intestine-specific endoderm (Beck et al. 1995; Silberg
et al. 2000) and adult intestinal epithelium (James et al.
1994). Forced expression in the developingmouse stomach
(Mutoh et al. 2002; Silberg et al. 2002), but not in adult
esophageal cells (Kong et al. 2011), induces enteric differ-
entiation. Although germline CDX2 loss is lethal, hetero-
zygote animals show focal stomach differentiation in the
hindgut (Beck et al. 1999). Conditional loss at approxi-
mately E9 causes colonic atresia and replacement of the
villous ileal mucosa by a stratified epithelium with Eso
andFS features (Gao et al. 2009). In contrast,Cdx2deletion
at E13 resulted in glandular stomach-likemorphology and
expression of gastric genes in the duodenum (Grainger
et al. 2010), whereas deletion in adult intestines induced
weak expression of few stomach genes (Verzi et al. 2010,
2011; Stringer et al. 2012) but precipitated lethal intestinal
failure owing to collapse of CDX2-dependent enhancers
(Verzi et al. 2013; Saxena et al. 2017). These studies impli-
cate CDX2 in the highly contextual control of intestinal
development and function. We postulated that investiga-
tionofCDX2–chromatin interactionsduringmousedevel-
opment might illuminate the underpinnings of tissue
competence, specification, and determination.
Results
Region-specific gene expression in the developing mouse
gut is associated with distinct profiles of open enhancer
chromatin
The gut endoderm generates a squamous lining in the Eso
and FS and distinctive columnar epithelia in the hind-
stomach (HS) and intestine (Zorn and Wells 2009). To
study transcriptional and chromatin dynamics that under-
lie this rostro–caudal patterning, we purified EPCAM+ en-
dodermal cells (Supplemental Fig. S1A; Sherwood et al.
2007) from discrete regions of the E12, E14, and E16
mouse gut (Fig. 1A): (1) the prospective FS and Eso, (2)
the area between the FS and gastric pylorus (HS), and (3)
the tube distal to the pylorus and proximal to the cecum
(midgut or small intestine [Int]). RNA sequencing (RNA-
seq) data from replicate samples (Supplemental Table
S1) were highly concordant, and regional markers attested
to the purity of cell isolates (Supplemental Fig. S1B). In
principal component analysis (PCA) (Fig. 1B) and correla-
tion analysis (Supplemental Fig. S1C), temporal changes
accounted for the largest variation in gene expression,
with mRNA profiles diverging by region after E12; these
findings agree with observations that the intestinal lining
is undifferentiated at E12 until villus primordia first ap-
pear at approximately E14 (Walton et al. 2012) andmature
thereafter (Fig. 1B). K-means clustering of genes differen-
tially expressed at E16 (q < 0.05, fold change ≥4, reads
per kilobase per million mapped reads [RPKM] >1) yielded
groups with expression restricted to the Eso/FS, the HS,
the Int, or two of these prospective epithelia (Supplemen-
tal Fig. S1D). These region-specific genes represent the
purpose of digestive tract patterning and reflect the out-
comes of spatio–temporal chromatin organization.
To determine the corresponding chromatin states, we
first used the assay for transposase-accessible chromatin
(ATAC) with sequencing (ATAC-seq) (Buenrostro et al.
2015) on Eso/FS, HS, and Int epithelia at postnatal day 1
(P1) (Supplemental Table S2). Replicate samples were
highly concordant, regional differences in open chromatin
were readily evident (Supplemental Fig. S2A,B), and dif-
fReps (Shen et al. 2013) identified genomic sites where
chromatin access differed by region (Supplemental Fig.
S2C). At sites located >2 kb away from transcription start
sites (TSSs), we thus detected candidate enhancers unique
to each organ and sites shared among two or all three tis-
sues (Fig. 1C). Areas selectively accessible in P1 intestine
showed active histone marks and RNA polymerase II
(Pol II) binding only in the adult intestine (Fig. 1C; Supple-
mental Fig. S2D), attesting that they are region-specific cis
elements, and GREAT (Genomic Regions Enrichment of
Annotations Tool) analysis (McLean et al. 2010) verified
that genes <50 kb from differential ATAC sites serve
region-specific roles (Supplemental Fig. S2E). Tissue-re-
stricted chromatin access of some cis-regulatory domains
was readily apparent at known tissue-specific loci (Fig. 1C;
Supplemental Fig. S2F,G), and binding and expression tar-
get analysis (BETA) (Wang et al. 2013) revealed association
of the Eso/FS and Int site clusters with genes highly en-
riched in the E16 Eso/FS and E16 Int, respectively (Fig.
1D). Because enhancers can act at distances >50 kb and
on loci other than the nearest gene (Shlyueva et al. 2014;
Long et al. 2016), such associations speak to likely activi-
ties of ATAC+ sites in aggregate and not the established
function of any given site. Nevertheless, for simplicity,
we refer to this collection of putative regulatory sites as
“enhancers.”
Open chromatin dynamics identify a likely basis for cell
fate plasticity in the developing intestine
To study trajectories of chromatin access that culminate
in the neonatal tissues, we used ATAC-seq to map open
chromatin in EPCAM+ cells purified from each regional
endodermat E12, E14, and E16. Figure 2Adisplays the nor-
malizeddata fromthese series (quantified inSupplemental
Fig. S3A,B) for every region-specific cluster. Although
each P1 profile was strongest and restricted in the corre-
sponding E16 epithelium, ATAC signatures in the FG
were apparent in the respective regions by E14, whereas
intestine-specific sites opened later (Fig. 2A). This differ-
ential trajectory is compatible with rostral-to-caudal pro-
gression of digestive tract differentiation, as judged by
morphology in diverse vertebrate species (Wells and Mel-
ton 1999; Grapin-Botton 2005). Notably, FG-restricted
profiles were evident at equal measure in all regions, in-
cluding the Int, at E12 andE14; someFGsites even showed
access in Int cells until E16. In contrast, a global viewof Int
Banerjee et al.
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enhancers revealed a lack of open chromatin at any time in
FG-derived endoderm (Fig. 2A). These findings were evi-
dent in independent replicates of Int endoderm and do
not reflect tissue contamination because the pylorus is
an unmistakable landmark at the FG–midgut boundary.
Nevertheless, we also examined Int endoderm at E11,
the earliest time that the Int and HS are visibly distinct
and EPCAM is restricted to the endoderm. FG enhancers
were as open in E11 Int endoderm as at E12 (Fig. 2A). As
open enhancer chromatin reflects the potential to express
nearby genes, these findings imply that before developing
the ability to express Int genes, midgut endoderm may
E
BA
C D
Figure 2. Extensive FG enhancermarking and activity in early Int endoderm. (A) ATAC-seq signals at region-specific P1 enhancers (from
Fig. 1C) at successive stages in each regional endoderm: Eso/FS and HS (FG) and Int (midgut). FG endoderm lacked open chromatin at Int-
specific enhancers at all times, whereas early Int endoderm showed extensive open chromatin at FG enhancers and loss of this chromatin
access by P1. (B) H3K27ac ChIP-seq (chromatin immunoprecipitation [ChIP] combined with high-throughput sequencing) signals in E12,
E14, and P60 Int endoderm (Kazakevych et al. 2017) at region-specific P1 enhancers. Early open chromatin at FG-specific enhancers is
associated with H3K27ac, and both features are later lost. (C ) Distributions of RNA levels among 824 Eso/FS-enriched genes (E16)
(from Supplemental Fig. S1D) showing comparable global expression in the Eso/FS, HS, and Int at E12, before expression becomes selec-
tively enriched in the Eso/FS. Dots in each violin plot representmedianmRNA counts, and the significance of differences between groups
was determined by theMann-WhitneyU-test. (n.s.) Not significant; (∗∗∗) P <0.01; (∗∗∗∗) P <0.0001. The table shows normalized RNA read
counts for representative region-specific genes, illustrating FG-specific gene activity in early Int endoderm. (D) A representative Eso/FS
locus, Sox15, carries open chromatin and H3K27ac in early (E11, E12, and E14) Int endoderm, later losing both features. Early, but not
late, H3K27ac is also shown at a representative HS locus: Gkn3. (E) Aggregate intestinal ATAC-seq (blue; left) and H3K27ac ChIP-seq
(brown; right) signals in the “Overlap,”HS, and Int enhancer clusters at different times. Chromatin access and H3K27ac at HS and “Over-
lap” enhancers decline during development, while both features arise at Int-specific enhancers.
Chromatin-based endoderm plasticity
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harbor the potential to activate FG-specific genes and, by
extension, for Eso/FS or HS differentiation. In contrast,
FGendodermappears to lack the reciprocal capacity for in-
testinal differentiation, at least by E12.
To ascertain whether open chromatin in Int bears other
enhancer features, we analyzed data on the active histone
markH3K27ac in E12 and E14 EPCAM+ Int endoderm and
adult epithelium (Kazakevych et al. 2017). Int-restricted
enhancers carried H3K27ac in E14 and adult intestinal
cells, as expected; so did many FG-specific sites in E12
and E14 intestinal endoderm (Fig. 2B). Both open chroma-
tin and H3K27ac at FG enhancers were abrogated in P1 or
adult Int cells (Fig. 2A,B), and to impute their cis-regulato-
ry activity, we examined RNA levels of region-specific
genes (Supplemental Fig. S1D), which the corresponding
regional enhancers control (Fig. 1D). Median mRNA lev-
els of FG genes were fourfold to >100-fold higher than
those of Int genes in E16 FG endoderm but were compara-
ble in E12 cells (Fig. 2C; Supplemental Fig. S3C). Eso/FS-
specific Sox15 (Sulahian et al. 2015), for example, shows
selectively high mRNA in the rostral FG by E16 but
even higher levels in Int than in Eso/FS at E12 (Fig. 2C).
Like many such loci, Sox15 and HS-restricted Gkn3 are
open and marked with H3K27ac in E12 Int endoderm
and lose these features over time, even as the same sites
gain enhancer features in the Eso/FS (Fig. 2D). These ob-
servations together reveal that thousands of FG enhancers
are measurably active in undifferentiated Int endoderm
and later decommissioned, concomitant with activation
of Int-specific enhancers and determination of Int cell
fate (Fig. 2E).
The timing of CDX2 loss strongly influences homeotic
intestinal transformation
Enhancer states represent the activities of sequence-
specific TFs and recruited coregulators (Long et al. 2016).
Indeed, motifs for known tissue-restricted TFs were the
most enriched among the respective P1 tissue-specific en-
hancers (Fig. 3A). These TF transcripts were present at low
levels in each E12 endoderm; over time, their levels in-
creased in the cognate endodermand declined reciprocally
in heterologous epithelia (Fig. 3B). Cdx2, however, stands
out because it is restricted to the intestine, as reported pre-
viously (Beck et al. 1995; Silberg et al. 2000), and peak lev-
els were achieved by E12, much before regional endoderm
specification. Conditional loss of Cdx2 at different devel-
opmental stages has varied consequences (Gao et al.
2009). To determine its tissue requirements in relation
to chromatin and TF dynamics, we deleted Cdx2 using
ShhCre, whichacts in the luminal gut endodermbyapprox-
imately E10 (Echelard et al. 1993). Jejunal villi were stunt-
ed and, in lieu of crypt-villus units, the ileum had a
stratified lining of the Eso/FS type (Fig. 3C, red arrows). Je-
junal glands expressed the gastric parietal cell marker
ATP4B at the base (Fig. 3C, white arrowheads), and, in
place of scattered periodic acid Schiff (PAS)-stained goblet
cells, duodenal and jejunal villi showed numerous gastric
BA
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Figure 3. ShhCre-mediated Cdx2 deletion re-
sults in anterior homeotic transformation. (A)
The highest enriched sequences within re-
gion-specific enhancer clusters represent ca-
nonical TF motifs. (B) Trajectories of Eso/FS-
and Int-specific TF transcripts in E12, E14,
and E16 Eso/FS (left) and Int (right) endoderm.
Log2 transformed RPKM values, plotted over
time, show increases and decreases in the dif-
ferent regions. (C ) Intestinal regions (from the
duodenum to the ileum) stained with PAS or
with ATP4B or TRP63 antibody in E18 wild-
type and ShhCre;Cdx2Fl/Fl embryos. In the mu-
tant duodenum and jejunum, gastric foveolar
cells (recognized by a mauve apical rim; black
arrows) extensively replace intestinal goblet
cells (recognized by a purple cytoplasmic
blob; black arrowheads). These contrasting fea-
tures of wild-type and mutant jejunal villi are
highlighted in the dashed boxes and magnified
at the right. In addition, ATP4B+ gastric parie-
tal cells appear in the mutant jejunal (white ar-
rowheads) but not duodenal crypts. The
mutant ileum loses crypt–villus structure, in-
cluding PAS+ goblet cells, and is lined instead
by TRP63+ stratified squamousmucosa (red ar-
rows). Bars, 25 µm.
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foveolar cells, where PAS classically stains the cellular
apex (Fig. 3C, black arrowheads and arrows, respectively).
Notably, these ectopic regional featureswerenot intermin-
gled: Squamous marker TRP63 was expressed in the
Cdx2−/− ileum but not the duodenum or jejunum, and,
conversely, ATP4B was present in the jejunum but not
the ileum (Fig. 3C). Thus, ShhCre-mediated CDX2 loss re-
sults in regionally confined alterations of endodermal
fate determination, distinct from those reported when
Cdx2 is deleted earlier using Foxa3Cre (Gao et al. 2009) or
later using Villin-CreER-T2 (Grainger et al. 2010).
CDX2 requirements to establish intestinal fate shift
during endoderm development
To study the transcriptional consequences ofCDX2deple-
tion at different times, we isolated ShhCre;Cdx2Fl/Fl intes-
tinal cells and treated pregnant Villin-CreER-T2;Cdx2Fl/Fl
dams (Grainger et al. 2010) with tamoxifen to activate
CRE on the 13th or 15th gestational day (Fig. 4A). When
we activated CRE at or before E13, we isolated epithelial
cells at E16 and (to give time for response to CDX2 loss af-
ter activating CRE at E15) E18. In every case, exon 2
mRNA (Supplemental Fig. S4A) and CDX2 protein (Fig.
4A) were depleted. ShhCre-driven loss of CDX2 yielded
mRNA profiles that were the most distinct from wild-
type E16 intestine and most similar to FG derivatives
(Fig. 4B). Considering region-specific RNA clusters (Sup-
plemental Fig. S1D), earlyCDX2 lossmarkedly attenuated
Int-specific genes and produced substantial overlap with
FG-restricted transcripts (Fig. 4C; Supplemental Fig.
S4B). In contrast, deletion at E13 decreased Int transcripts
modestly, and fewerFGgeneswere concomitantlyactivat-
ed,whereas deletion atE15 resulted invirtuallynoFG-spe-
cific gene expression (Fig. 4C), similar to adult Cdx2−/−
jejunum (Verzi et al. 2013).Moreover, afterCREactivation
E F
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Figure 4. Time-sensitive activation of FG-specif-
ic transcriptional programs in the absence of
CDX2. (A) Schema of Cdx2 deletions mediated
by either ShhCre (approximately E10) or treatment
of Villin-CreER-T2 dams with tamoxifen at E13 or
E15. Embryos deleted before E14 were assessed
at E16, and those deleted at E15 were assessed at
E18. CDX2 immunostains verify protein loss. (B)
Unsupervised hierarchical clustering (Pearson co-
efficients) for the 2604 genes expressed differently
(greater than fourfold, q<0.05) in E16 wild-type
tissues (Supplemental Fig. S1D) and E16 Cdx2−/−
Int after deletion at approximately E10 or E13.
Transcriptomes in early, but not late, Cdx2-
deleted Int endoderm resemble those in FGepithe-
lia. (C ) mRNA differences in Cdx2−/− Int after
deletion at approximately E10 (n=3), E13, or E15
or in adult duodenum and ileum (n= 2 each). Clus-
ters are those with differential expression in wild-
type E16 EPCAM+ Eso/FS, HS, and Int cells (from
Supplemental Fig. S1D). For each FG cluster, col-
ored violin plots represent the distributions of
mRNA levels (colors represent the region, and
white dots represent the median) in wild-type tis-
sues, and gray violins show the distributions after
Cdx2 deletion (knockout) at different times. Vio-
lin plots for Int genes are shown in Supplemental
Figure S3B. The Mann-Whitney U-test was ap-
plied to determine the significance between
Cdx2knockout at different times. (n.s.) Not signif-
icant; (∗) P< 0.05; (∗∗∗∗) P <0.0001. (D–F ) IGV
tracks of RNA-seq data showing native (wild-
type FS, HS, and Int) and ectopic FG gene expres-
sion in Cdx2−/− intestines after deletion at E10,
E13, or E15. Numbers represent the scale for nor-
malized read counts.
Chromatin-based endoderm plasticity
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in adult mice, duodenal and ileal Cdx2−/− villus cells did
not show significant levels of FG transcripts (Fig. 4C).
Thus,CDX2depletionmarkedlyaffects bothFGand intes-
tinal geneactivity,with the largest effect onbothprograms
occurring after early loss of CDX2 and progressively less
disruption upon later losses.
Several features of FG gene activity in developing
Cdx2−/− intestines merit note. First, at any time of CDX2
loss, not all FG-specific genes were activated (Supplemen-
tal Fig. S4C). Expression of canonical Eso/FS and HS genes
explains the FG morphology when Cdx2 was deleted by
E10 (Figs. 3C, 4D; Supplemental Fig. S4D), but other
wild-type FG transcripts were never detected in the
Cdx2−/−midgut (Fig. 4E). Second, FG-specific mRNA lev-
els in mutant intestines approached and often exceeded
the native levels in the wild-type Eso or stomach (e.g.,
see Fig. 4D,F; Supplemental Fig. S4D), indicating robust
ectopic gene activity. Third, transcripts expressed in
both the wild-type Eso and stomach (“overlapping”) ac-
counted for a substantial fraction of aberrant gene activity
(Fig. 4C,D; Supplemental Fig. S4C), in line with the abun-
dance of open chromatin at corresponding loci in thewild-
typeE11–E14midgut (Fig. 2A). Fourth,whereasCdx2dele-
tion at E13 activated fewer FGgenes andwith less strength
than deletion by ShhCre, some genes (especially overlap-
ping and HS) were activated only after E13 deletion (Fig.
4F; Supplemental Figs. S4C,E). Finally, although global
mRNA profiles after Cdx2 deletion at E15 suggested al-
most no FG gene activity, ∼20% of genes were activated
greater than fourfold (Supplemental Fig. S4F).
These findings collectively demonstrate that midgut
endoderm is initially biased toward FG differentiation
and that CDX2 helps override this latent potential. Al-
though midgut competence subsequently narrows, dele-
tion of Cdx2 as late as E13 increases intestinal mRNA
levels of 53% of gastric genes by greater than twofold
and 43% of gastric genes by greater than fourfold. By
E15, however, the window for FG gene activity is closed
and, except at a few residual enhancers, no longer requires
CDX2 to prevent it. Of note, mRNA (Fig. 1B) and open
chromatin (Fig. 2A) trajectories in wild-type embryos re-
veal a crucial transition at approximately E14, and Cdx2
deletion through E13 reflects the same window of time,
when endoderm is yet undetermined and FG genes can
be stably activated in the midgut.
CDX2 loss at different times produces distinct tissue
defects and open chromatin profiles
Foxa3Cre-driven loss did not induce gastric morphology or
ectopic stomach transcripts (Gao et al. 2009), whereas
deletion at E13 induced HS cells only in part of the proxi-
mal duodenum and scant expression of gastric genes
(Grainger et al. 2010).ShhCre-mediatedCdx2deletion like-
ly occurs between these times and, in addition to ileal squ-
amous differentiation, induces overt gastric features in the
proximal and mid-intestine and robustly activates FG
genes. The lower levels of FG-restricted transcripts when
Cdx2 was deleted at E13 or E15 predicted that anterioriz-
ing homeotic transformation may be reduced or absent
at the later times. Indeed, following Cdx2 deletion at E13
or E15, PAS staining throughout the intestine showed fea-
tures of intestinal goblet—not gastric foveolar—cells, and
the ileumdid not carry a stratified epitheliumbut a typical
columnar villous type (Fig. 5A). Thus, strikingly different
phenotypes ensue whenCdx2 is deleted at different times
(Supplemental Fig. S4G), mirroring the inherent early ac-
cessibility and subsequent closure of FG enhancers.
The CDX2 sequencemotif is enriched only at intestine-
specific and not at FG-specific enhancers (Fig. 3A). Never-
theless, CDX2’s potent role in preventing FGgene activity
could reflect repressive action from binding at FG enhanc-
ers or an indirect effect exerted by other means. To distin-
guish among these possibilities, we used CDX2 antibody
for ChIP (chromatin immunoprecipitation) on EPCAM+
wild-type midgut endodermal cells, where it appeared at
Int-specific enhancers by E14, and binding strengthened
over time. In contrast, FG-specific enhancers globally
showed negligible binding at E14 or E13, the earliest times
that ChIP was feasible (Fig. 5B; Supplemental Fig. S5A),
and inspection of individual FG sites failed to reveal
appreciable CDX2 signals (Fig. 5C). This absence did not
reflect ChIP insensitivity because binding at E13 and E14
was evident at other H3K27ac-marked enhancers with
open chromatin (Supplemental Fig. S5B). Rather, themin-
imal overlap of E13 binding sites with regions of open
FG-specific chromatin (Fig. 5D) implies that CDX2 pre-
cludes FG gene activation indirectly. In contrast, the sites
and chronology of CDX2 binding at E14 and E17 (Fig. 5B)
correlate with, and may underlie, intestine-specific gene
activity.
To ascertain how FG- and Int-specific areas of open
chromatin respond to loss of CDX2, we deleted Cdx2 at
various times and assessed Int endoderm by ATAC-seq.
As with mRNA profiling, when Cdx2 deletion occurred
at E10 or E13, we studied EPCAM+ cells at E16, and,
whenCdx2 deletion occurred at E15,we examined epithe-
lial cells 3 d later.We also examined adultCdx2−/− epithe-
lium that we harvested from the ileum, the region of
highest native expression (Silberg et al. 2000) and the
most severely affected after embryonic (Fig. 3C) or adult
(Verzi et al. 2010) CDX2 loss. ShhCre-driven loss of
CDX2 andVillinCre-mediated loss at E13 caused amarked
persistence of open chromatin at FG-specific enhancers,
especially at “overlapping” and HS sites (Fig. 6A; Supple-
mental Fig. S5C,D). Among genes up-regulated after E10
deletion (Fig. 4C), 31% of TSSs lie <25 kb and 46% lie
<50 kb from these areas of aberrantly open chromatin
(Fig. 6B), and BETA analysis (Wang et al. 2013) confirmed
strong statistical association (Supplemental Fig. S5E).
Also in response to early Cdx2 deletion, intestinal en-
hancers lacked open chromatin, indicating failure of intes-
tinal gene activation. In contrast, deletion at E15 or in
adults diminished intestinal ATAC signals to a lesser de-
gree and failed to hold chromatin open at FG-specific en-
hancers (Fig. 6A; Supplemental Fig. S5C). These data
identify a basis in chromatin for TF-dependent fate deter-
mination across thousands of region-specific cis elements
(Fig. 6C). They also demonstrate CDX2’s dual role in de-
commissioning FG enhancers without direct binding
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and in establishing intestine-specific enhancers where
CDX2 occupancy is pervasive.
Discussion
This study of mouse endoderm across developmental
space and time reveals substantial chromatin, transcrip-
tional, and cell fate plasticity foreshadowing the commit-
ment to a unique epithelial identity. We report two core
findings. First, before the midgut endoderm activates
an intestine-specific transcriptional program and adopts
villous morphology, enhancers that control FG-specific
genes arebroadly accessible to the samedegree as inFGen-
doderm. At least after E11, the reverse is not true: Intesti-
nal enhancers were inaccessible in multiple EPCAM+ cell
isolates from the FS (future squamous) or HS (future glan-
dular stomach). Beyond having accessible chromatin and
the active histone mark H3K27ac, FG-specific genes near
these cis elements are expressed in earlymidgut endoderm
to levels at least the same as—and often higher than—the
same transcripts in early FG endoderm. Together, these
findings indicate that early midgut endoderm enhancers
carry the potential to activate FG genes, and the tissue
can therefore differentiate into stratified or glandular gas-
tric epithelia. Thus, tissue determination reflects the im-
position of intestinal—at the expense of FG—identity.
Our observations mirror those showing broad priming of
enhancers in human ESC-derived endoderm before differ-
entiation of the pancreatic lineage (Wang et al. 2015). It is
unclear why many FG genes express at even higher levels
in early midgut than in FG endoderm (Fig. 2C). At a mini-
mum, our findings imply that crucial FGTFs arepresent in
midgut endodermand can engage accessible FGenhancers
to drive transcription of FG genes.
A second core finding reveals the finite window in
which CDX2 acts to suppress alternative tissue identity.
Depletion of CDX2 at approximately E10 induces Eso/
FS differentiation in the distal midgut, glandular HS dif-
ferentiation in the proximal midgut, and failure to acti-
vate Int-specific genes. By E15 and in adult mice, acute
CDX2 loss diminishes Int-specific transcripts but barely
affects FG genes, whereas loss at E13 has an intermediate
effect: activation of many FG-specific genes without in-
duction of overt FG histology. Importantly, the window
in which CDX2 is required to set chromatin marking
and accessibility patterns (thus overcoming FG gene ac-
tivity)—before but not after E14—coincides with that of
initial epithelial divergence (Fig. 1B) and FG enhancer de-
commissioning in the wild-type midgut (Fig. 2A). Thus,
CDX2 loss before E14 stabilizes intrinsically accessible
FG enhancers, which are subsequently unavailable to sta-
bilize. These findings reveal the gene regulatory logic of
rostro–caudal gut tube patterning and a chromatin basis
for determination of one epithelial fate at the expense of
others. Of note, our study examined only antero-posterior
patterning of the luminal gut; development of other endo-
derm derivatives—the liver, pancreas, and lungs—may
use the same or different regulatory logic.
The fact that FG enhancers open earlier than intestinal
enhancers is consistent with observations that vertebrate
gut endoderm differentiates in an anterior-to-posterior
wave (Wells and Melton 1999; Grapin-Botton and Melton
2000). Moreover, judging by both profiles of open chroma-
tin and the outcomes of Cdx2 deletion at different times,
anterior (FG) potential predominates throughout the early
BA
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Figure 5. CDX2 binding in developing Int endoderm
and the consequences of late depletion. (A) PAS staining
of intestinal regions after Cdx2 deletion at E13 or E15.
Wild-type and mutant Ints were assessed at E18. Goblet
cells (black arrowheads) were intact, and no region
showed gastric foveolar differentiation (no cells were ob-
served with apical rim staining). Bar, 25 μm. (B) Normal-
ized ChIP-seq data for CDX2 at different developmental
stages. Binding at enhancers from any regional cluster is
minimal at E13; thereafter, it increases progressively and
selectively at Int enhancers. (C ) Lack of CDX2 binding at
P1 FG enhancers (red- and gold-shaded areas). The blue-
shaded box demarcates a CDX2-bound intestinal en-
hancer. Numbers represent the scales of ChIP or ATAC
signals. (D) E13-specific CDX2-bound sites overlap min-
imally with FG-specific enhancer regions, implying the
absence of direct CDX2 control over FG genes.
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tubal endoderm and is superseded gradually by posterior
(intestinal) fate in the midgut (Fig. 6D). Consequently, in
the absence of factors that impose intestinal fate, distal re-
gions may remain susceptible to anterior homeotic trans-
formation for a longer time than proximal regions, which
explains nicely why squamous differentiation is confined
to the ileum when Cdx2 is deleted at or before approxi-
mately E10. We note, however, that whenCdx2 is deleted
by ShhCre, prominent HS differentiation ensues in the je-
junum (Fig. 3C), a homeotic transformation not seen with
earlier deletion using Foxa3-Cre (Gao et al. 2009). To ex-
plain this difference, we postulate that Eso/FS and HS po-
tential sweep through midgut endoderm in successive
waves, each countered by CDX2-imposed intestinal iden-
tity. In terms of chromatin, Eso/FS-specific enhancers still
dominate in the prospective ileum at approximately E10
(ShhCre), hence favoring squamous cell differentiation,
while HS-specific enhancers have supplanted them in
the future jejunumand promote gastric glandular differen-
tiation. Meanwhile, Int-specific enhancers may replace
both Eso/FS and HS enhancers early in the anterior mid-
gut, so the prospective duodenummanifests intestinal po-
tential when Cdx2 is deleted using either Foxa3-Cre or
ShhCre. Because our molecular analyses probed the whole
intestine, they lack the spatial resolution to confirm the
details of this model (Fig. 6D), a limitation that also ap-
plies to other aspects of the study. For example, chromatin
at thousands of “overlapping” and HS-specific enhancers
was open in wild-type midgut endoderm until approxi-
mately E14, but we did not detect access at the global
pool of FS-only enhancers. Moreover, depletion of CDX2
as early as E10 stabilized only “overlapping” and HS-
unique enhancers and activated nearby genes but did
not open FS-only sites, at least as detected in whole Int
endoderm. Possibly, these enhancers were transiently
open in the midgut before E11, or the signal was obscured
because it was confined to small portions of the posterior
wild-type and Cdx2−/− midgut; alternatively, different
patterning mechanisms may apply early and late in endo-
derm development. Distinguishing among these possi-
bilities will require fine resolution of chromatin states
in various regions of the E9–E11 midgut using gene-
linked cell sorting or single-cell approaches to examine
tiny cell populations before anatomic landmarks become
clear.
Together with the tissue defects that result from CDX2
loss, the enhancer accessibility dynamics indicate that
without intestinal TF activity, FG fates represent the
B
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Figure 6. Persistence of open chromatin at
FG enhancers after early, but not late,
CDX2 loss. (A) Mice were treated to induce
Cdx2 deletion according to the schema in
Figure 4A, and isolated Int epithelium was
assessed for accessible chromatin by
ATAC. “Overlap” and HS enhancers,
which are ordinarily open in wild-type em-
bryos until E14 (Fig. 2A), remained accessi-
ble after Cdx2 deletion at approximately
E10 or E13 but were closed after Cdx2 dele-
tion at E15 or in adult mice. Intestinal en-
hancers were significantly compromised
after early, and less compromised after
late, Cdx2 deletion. The IGV track shows
a representative locus: Foxp4. Shaded boxes
denote Eso/FS- and HS-specific enhancers
showing open chromatin after early Cdx2
deletion. (B) The fractions of genes up-regu-
lated in E10Cdx2−/− intestines (gray) locat-
ed 25 or 50 kb away from “overlapping” or
HS enhancers where ATAC signals persist
in E10 Cdx2−/− intestines. (C ) Model for
the temporal relation of enhancer accessi-
bility to tissue plasticity in wild-type endo-
derm (top), as inferred from Cdx2−/−
intestines (bottom). IGV tracks show origi-
nal ATAC-seq peaks at representative FG-
and Int-specific enhancers located far from
the respective TSSs. (D) Model depicting
midgut developmental potential as a func-
tion of temporally regulated waves of en-
hancer accessibility and region-specific
mRNA expression. Low-level expression
of FG genes is initially pervasive, while FG enhancers are accessible throughout the gut tube. Regional determination occurs after E14,
when enhancer signatures become consolidated, gene expression domains become restricted, and regional anatomy approaches adult
forms.
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default outcome ofmammalian endodermdifferentiation.
After FG potential is relinquished (approximately E14),
however, loss of CDX2 alone is insufficient to restore it.
Forced CDX2 expression also has different outcomes in
the fetal mouse stomach, which develops with intestinal
features (Mutoh et al. 2002; Silberg et al. 2002), and in
adult gastric organoids, which, for the most part, retain
stomach identity (Simmini et al. 2014). Thus, CDX2 can
impose intestinal identity only during the brief window
in development when enhancer dynamics permit choices
among digestive endoderm fates. Such functions are not
restricted to CDX2 and the intestine. SOX2 deficiency,
in particular, results in a posterior homeotic transforma-
tion of the FS, with reduced keratinization and a columnar
HS-type epithelium (Que et al. 2007), whereas continuous
ectopic SOX2 expression in the midgut after E8.5 induces
anterior homeosis with marked stomach differentiation
(Raghoebir et al. 2012). SOX2 and CDX2 first appear at
E7.75 in themost anterior and posterior endodermal cells,
respectively, and their domains extend progressively to-
ward the FG–midgut boundary, where the two TFs are
coexpressed briefly before becoming mutually exclusive
near the gastric pylorus by E9.5 (Sherwood et al. 2009).
These temporal waves of expression—likely controlled
by retinoic acid, BMP, and Wnt signaling posteriorly and
by inhibition of these pathways anteriorly (Wells and
Spence 2014; Davenport et al. 2016)—suggest how TF ex-
pressionandchromatindynamics together specifyalterna-
tive endodermal fates. We propose further that initially
accessible heterologous enhancers get decommissioned
indirectly through mutual cross-repression by region-re-
stricted TFs such as SOX2 and CDX2.
In conclusion, our findings offer a basis in chromatin for
classical and recent observations on endoderm plasticity
and determination. The repertoire of available enhancers,
likely established by positional cues, dictates the limited
spectrum of possible cell fates. As late as mid-gestation,
the basis for cell plasticity is that different TFs can rein-
force different sets of accessible tissue-specific enhancers
and allow the remaining open sites to close. Irrevocable
commitment to one adult cell fate (determination) fol-
lows when specific TFs have reinforced the correct com-
plement of cis elements, and the enhancers that enable
alternative cell identities are no longer available. Similar
enhancer logic and plasticity likely underlie the differen-
tiation of other organs.
Materials and methods
Experimental mice and treatments
Wild-type CD1 mice were purchased from Charles River Labora-
tories. Cdx2Fl (Verzi et al. 2010), ShhEgfp-Cre (ShhCre) (Harfe et al.
2004), and Villin-CreER-T2 (el Marjou et al. 2004) mice were re-
ported previously. The morning of a vaginal plug was regarded
as E0. Embryos from crosses between ShhCre;Cdx2Fl/+ male and
Cdx2Fl/Fl female mice were used to isolate intestinal RNA or
chromatin and subsequently genotyped to distinguish Cdx2-
null from Cdx2Fl/Fl;Cre- and Cdx2+/+;Cre+ controls. To delete
Cdx2 at later times, pregnant dams received 5 mg of tamoxifen
(Sigma, T5648) dissolved in 0.5 mL of corn oil by oral gavage.
Adult Cdx2Fl/Fl;Villin-CreER-T2 mice received five daily intraper-
itoneal injections of tamoxifen (1 mg per 25 g of body weight or
higher) prepared in corn oil and were euthanized on the third
day after the last injection. Cre− mice served as littermate con-
trols. All animal experiments were approved and monitored by
Animal Care and Use Committees at Dana-Farber Cancer Insti-
tute and Rutgers University.
Tissue collection and cell isolation
Embryos were collected in ice-cold phosphate-buffered saline
(PBS), and the digestive tract was collected in ice-cold Hank’s ba-
lanced salt solution (HBSS; Thermo Fisher). The rostral half of
E12 and E14 stomachs was considered the FS, and the caudal
half was considered as the HS. In E16 embryos and neonates,
the visible squamo–columnar junction was applied to separate
the FS from the HS, discarding the interim zone. Intestines
were harvested from 1mm distal to the pylorus until (but exclud-
ing) the cecum. Tissues were digestedwith 0.25%Trypsin-EDTA
(Thermo Fisher) for 30min at 37°C. Releasedmaterial was passed
over 40-µm filters (Corning) to obtain single cells. Neonatal intes-
tines were washed with ice-cold PBS and incubated in 5 mM
EDTA solution in PBS at 4°C with gentle shaking for 30 min
to release villus epithelium. Suspensions were passed through
70-µm filters (Corning) to retain villi, which were washed in
cold PBS and dissociated into single cells by incubation in 4× Try-
pLE solution (Thermo Fisher) for 30 min at 37°C. After neutrali-
zation with 5% FBS, cells were strained over 40-µm filters,
pelleted at 1200g for 5 min, resuspended in FACS buffer (PBS,
5mMEDTA, 2%FBS), and stainedwithAPC-conjugated EPCAM
antibody (1:100; Biolegend) for 1 h at 4°C in FACS buffer.
EPCAM+ cells were sorted on an Aria II SORP flow cytometer
(Becton-Dickinson). In some experiments, single cells were incu-
batedwith anti-CD326 (EPCAM) antibody conjugated tomagnet-
ic microbeads (Miltenyi Biotec, 130-105-958) for 40 min on ice
and then collected over MS Columns (Miltenyi Biotec, 130-042-
201) in a magnetic field. The purity of EPCAM+ cells isolated
by magnetic beads or flow cytometry was comparable. All repli-
cates in the study refer to biological replicates collected on differ-
ent days. In rare experiments lacking a biological replicate, data
from other samples or time points support the conclusions.
RNA-seq, ATAC-seq, and ChIP-seq (ChIP combined with high-
throughput sequencing)
Total RNA was isolated from FACS-sorted epithelial cells using
TRIzol (Thermo Fisher) and RNeasy microkit (Qiagen). Libraries
were prepared using the SMARTer-Seq version 4 low-input
mRNA library kit (Clonetech). Five-thousand to 30,000 cells
were used for ATAC-seq as described previously (Buenrostro
et al. 2015), with minor modifications. Cells were lysed in ice-
cold buffer (10 mM Tris at pH 7.4, 10 mM NaCl, 3 mM MgCl2,
0.1% [v/v] Igepal CA-630), and nuclei were precipitated by centri-
fugation at 500g for 10min at 4°C were treated with Nextera Tn5
transposase (Illumina, FC-121-1030) for 30 min at 37°C. Trans-
posed chromatin was purified with QIAquick PCR purification
kits (Qiagen) and amplified with High-Fidelity 2X PCR Master
Mix (New England Biolabs) using a universal forward primer
and unique reverse primers in a 50-µL reaction for five cycles.
Fivemicroliters of the reactionmixwas amplified by quantitative
PCR for 20 cycles to determine the optimumnumber of addition-
al cycles, defined as one-third the number needed to achievemax-
imum fluorescence intensity. Primer dimers were excluded from
these PCR-amplified libraries using Agencourt AMPure XP beads
(Beckman Coulter).
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For fetal ChIP-seq, intestines were dissected from up to 36 em-
bryos in ice-cold HBSS and disrupted by vigorous pipetting fol-
lowed by cross-linking in 1% formaldehyde for 20 min at room
temperature, incubation for 10 min on ice in chromatin prepara-
tion buffer (ChIP-IT high-sensitivity kit, Active Motif, 53040)
with protease inhibitors (Roche, 11873580001) and phenyl meth-
yl sulfonyl fluoride (PMSF), and centrifugation at 1250g for 5 min
at 4°C. The pellet was resuspended in 0.5 mL of ChIP buffer
(ChIP-IT high-sensitivity kit, Active Motif) and incubated for
10min on ice. Lysates were sonicated in an E220 focused ultraso-
nicator (Covaris). CDX2 antibody-bound (Cell Signaling Technol-
ogy) protein A and protein G magnetic Dynabeads (1:1 ratio;
Thermo Fisher) were incubated overnight at 4°C with 2 µg of
chromatin in 300 µL of ChIP buffer containing protease inhibitors
and two carriers: 20 µL of recombinant human histone H2B solu-
tion (New England Biolabs, M2505S) and 1 µL of carrier RNA
from the RNeasy microkit (Qiagen, 74004). Beads were washed
five times with LiCl-RIPA buffer (10 mM Tris-HCl at pH 8, 500
mM LiCl, 1 mM EDTA, 1% NP-40) and once in 10 mM Tris-
EDTA (pH 8). Beads resuspended in 100 µL of immunoprecipita-
tion elution buffer containing 25 µg of RNase A were incubated
for 30 min at 37°C followed by 1 µL of 20 mg/mL proteinase K
(Active Motif), and cross-links were reversed overnight at 65°C.
DNAwas purified usingMinElute PCRpurification kits (Qiagen).
ChIP-seq for adult villi with CDX2 (Cell Signaling Technology,
12306) or H3K4me1 (Diagenode, C15410194) antibody was as de-
scribed previously (Saxena et al. 2017). Librarieswere prepared us-
ing ThruPLEX kits (Rubicon, R400427).
All librarieswere sequenced on aNextSeq 500 instrument (Illu-
mina) to generate 75-base-pair (bp) single-end reads.
Histochemistry and immunohistochemistry (IHC)
Intestines were fixed overnight in 4% paraformaldehyde, washed
in PBS, dehydrated in an ethanol series, and embedded in paraffin
to prepare 5-μm-thick sections. Slides were incubated in 0.5% pe-
riodic acid and stainedwith Schiff’s reagent (Alfa Aesar, J612171),
and alkaline phosphatase (ALPI) activity was measured using AP
staining kit II (Stemgent). For IHC, antigens were retrieved in
10 mM sodium citrate buffer (pH 6), and sections were then
incubated overnight at 4°Cwith antibody against CDX2 (Cell Sig-
naling Technology, 12306), ATP4B (MBL International Corp.,
D032-3), or TRP63 (Santa Cruz Biotechnology, sc-8343) followed
by biotin-conjugated anti-rabbit or anti-mouse IgG (Jackson Lab-
oratories); washed; and stained with Vectastain Elite ABC kit
(Vector Laboratories) and 3,3′ diaminobenzidine tetrahydrochlor-
ide (Amresco, 0430).
RNA-seq analysis
Reads were aligned to the mouse reference genome Mm9 (NCBI
build 37) using STAR aligner version 2.5.3a (Dobin et al. 2013),
and raw read counts from HTSeq (Anders et al. 2015) were used
to estimate transcript levels. Unsupervised PCA was performed
on log2 transformed normalized counts using R (https://www.
r-project.org). We then used DESeq2 (Love et al. 2014) to normal-
ize data using size factors or rlog transformation from E16 wild-
type FS, HS, and Int (n=2 samples each) and identify significant
(q <0.05) differential expression. RPKM values were calculated
using Cufflinks (Trapnell et al. 2012). Pearson correlation coeffi-
cients of normalized count values from biological replicates (n
≥ 2 samples each) were calculated using the corrgram package
in R. Data tracks to visualize on the IntegrativeGenomics Viewer
(IGV) version 2.3 (Robinson et al. 2011) were generated using
bamCoverage modules in deepTools2 (Ramirez et al. 2016). We
determined optimal cluster numbers for K-means clustering of
rlog transformed counts using the clusGap function in R, derived
Gene Ontologies in DAVID (Huang et al. 2009), and generated vi-
olin plots using the ggplot2 package (Wickham 2009) in R studio.
We used GENE-E software (Broad Institute) to plot log trans-
formed values in heat maps.
To determine genes associated with P1 Eso/FS- and Int-specific
enhancer clusters (Fig. 1) and up-regulated genes associated with
retained FG enhancers (Supplemental Fig. S5E), we used BETA
(Wang et al. 2013). Enriched expression of gene sets in the FS or
Int was determined using gene set enrichment analysis (GSEA)
(Subramanian et al. 2005), and normalized enrichment scores
were derived using 1000 permutations of random gene sets of
the same size. RNA-seq data fromwild-type andCdx2−/− (deleted
at E10) intestines were associated with a merged set of HS and
“overlapping” ATAC+ sites persisting in E10 deleted Cdx2−/−
intestines.
ATAC-seq and ChIP-seq analyses
For ChIP-seq, 75-bp single-end reads were aligned to mouse refer-
ence genomeMm9 (NCBI build 37) using Bowtie2 (Langmead and
Salzberg 2012). Following routine quality control, we reassessed
all ATAC-seq data and aligned reads using the ENCODE pipeline
(Supplemental Tables S1, S2). Nonunique and duplicate reads
were removed using SAMtools version 1.3.1 (Li et al. 2009). We
used individual or merged raw signals from replicate ChIP-seq
andATAC-seq files tovisualize in IGVtracksand thencreatedBig-
wig filesusing thebamCoveragemodule indeepTools2.Datawere
quantile-normalized using Haystack version 0.4 (Pinello et al.
2014) followedbydeepTools2 toplotheatmaps.ATAC-seqsignals
were computed using SitePro in Cistrome tools (Liu et al. 2011),
and intensity valueswere used to plot cumulative signals usingR.
Differential ATAC-seq signals between tissue pairs were iden-
tified using DiffReps version 1.55.4 (Shen et al. 2013) with z-score
cutoff of 5, window size of 500 bp, step size of 100 bp, and P-value
of 0.05. Enhancers were defined by excluding promoters (±1 kb
from a TSS). We then used BEDTools (Quinlan and Hall 2010)
to determine the overlap between the FS and HS in the DiffReps
output. These overlapping regions were subtracted from the indi-
vidual FS and HS sets and assigned to a distinct “Overlap” set,
while others were considered specific to one region or the other.
Similarly, sites common or unique to FS versus Int and HS versus
Int pairs were determined by intersecting with the set of Int-spe-
cific regions. To identify the shared regions, peaks were called us-
ing MACS2 (Zhang et al. 2008) for each tissue and intersected
using BEDTtools, excluding promoters.
To determine correlations between samples, normalized read
counts from replicate samples were collated over merged called
peaks (generated by MACS2) from individual bam files using
BEDTools. To determine cross-correlations, read countswere col-
lated over peak files merged from each sample and plotted in
R. Functions of genes within prescribed distances from ATAC
sites were identified using GREAT version 3.0 (McLean et al.
2010), and motif enrichment was identified using HOMER ver-
sion 4.7.2 (Heinz et al. 2010) based on cumulative binomial distri-
butions against the genome background. ChIP-seq andATAC-seq
read counts ±250 bp from peak summits were calculated from
normalized data and are represented as log transformed values
in violin plots. Differences among groups were determined using
the Kolmogorov-Smirnov test. As P-values were generally sig-
nificant (<0.0001 to <0.01) owing to large input sample sizes,
we inferred similarities and differences using the D statistic,
the maximum distance between two cumulative distribution
functions (e.g., see Supplemental Figs. S3B, S5C).
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Data availability
All data have been deposited in the Gene Expression Omnibus,
series GSE115541.
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